OOIR: Observatory of International Research

Papers

(The TQCC of Climacteric is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Peer reviewers for Climacteric in 2024	174
Safety and acceptability of intravaginal rings releasing estradiol and progesterone	90
Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted	65
Low thrombin generation in postmenopausal women using estetrol	60
Expanding knowledge across medical specialties in menopause research and practice: why it is so important for women’s health	52
Effects of jazz dance and concurrent training on physical variables in postmenopausal women	45
Variations in the prevalence of premature and early menopause in low and middle-income regions: a cross-sectional study	40
Influence of estradiol deficiency on the mineralocorticoid receptor response in postmenopausal women: a cross-sectional study	39
Peer reviewers for Climacteric in 2022	37
Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia	35
Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women	29
Androgen therapy in midlife and older women: a position statement of the Latin American Association of Gynecological Endocrinology (ALEG)	29
Women’s experience and management of cognition during menopause transition: a qualitative study	28
The musculoskeletal syndrome of menopause	25
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy	25
Awareness of menopause and menopause hormone therapy in India: perspectives of healthcare providers and consumers	24
Ultra-low-dose estradiol and dydrogesterone for treatment of vasomotor symptoms in Europe and China	23
Quo vadis?	21
Good night and good luck	20
Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis	20
Association of serum uric acid with handgrip strength and dynapenia in postmenopausal women	20
The impact of ovarian aging on muscle strength and life quality in various reproductive aging stages	19
Comparison of predicted aerobic capacity to measured aerobic capacity in menopausal women: an analysis of three methods	17
Treatment, perceptions and burden of vasomotor symptoms among midlife women in Japan	17
‘Menopausando’: a digital health education platform for women in the transition to menopause and postmenopause	16

Menopausal symptoms among perimenopausal women in rural Turkey: a cross-sectional study	16
Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA	16
Hormone therapy and insulin resistance in non-diabetic postmenopausal women: a systematic review and meta-analysis	16
Not just sex: other roles for testosterone in women	15
Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause	15
What is the evidence for the effect of physical exercise on bone health in menopausal women? An umbrella systematic review	15
VDRgeneApaI polymorphism and risk of postmenopausal osteoporosis: a meta-analysis from 22 studies	15
The LADY study: epidemiological characteristics of prevalent and new genitourinary syndrome of menopause cases in Greece	15
Practices and challenges in the management of the menopause in the Asia-Pacific Menopause Federation	14
Thank you	14
NK3 receptor antagonist alters the centrally controlled perception of menopausal flushing – a pilot study	14
Low-dose and ultra-low-dose estradiol and dydrogesterone in postmenopause: an analysis by body mass index	14
Factors influencing seogeulpeum among middle-aged Korean women	13
Younger midlife females with bilateral salpingo-oophorectomy: respiratory disturbances during sleep	13
Follicle stimulating hormone, luteinizing hormone and adiposity trajectories in postmenopausal women	13
Correction	13
Progesterone and not estrogens or androgens causes breast cancer	12
Reproductive milestones across the lifespan and cardiovascular disease risk in women	12
Oxidative balance score and periodontitis in postmenopausal women: a nationwide study	12
Understanding experiences and views of the menopause in Zimbabwe and South Africa: a qualitative study	12
Impact of overweight and obesity in postmenopausal women	11
Systemic hormone therapy after breast and gynecological cancers: an Italian expert group consensus opinion	11
Menopausal age and cardiovascular disease risk in American women: evidence from the National Health and Nutrition Examination Survey	11
POESIT recommendations on management of body-identical hormones in menopausal symptoms	11
Safety of menopause hormone therapy in postmenopausal women at higher risk of venous thromboembolism: a systematic review	11
COVID-19-related premature ovarian insufficiency: case report and literature review	11
The next chapter	11
Management of obesity in menopause	10
The yin and yang of GSM and low sexual desire	10
Adjuvant treatment with tamoxifen for estrogen receptor-positive breast cancer and gynecological risks in premenopausal and perimenopausal women – a systematic review	10
Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis	10
Management of menopause: a survey of physicians from the Middle East and Africa	10
Is the patients’ fear of cancer the main barrier to prescribing menopausal hormone therapy?	10
Menopause hormone treatment after cancer	10
Estrogen as a guardian of auditory health: Tsp1–CD47 axis regulation and noise-induced hearing loss	9
Complementary therapies for management of menopausal symptoms: a systematic review to inform the update of the International Menopause Society recommendations on women’s midlife health	9
Age and diagnostic assessment of natural menopause in low-weight women	9
FNDC5/Irisin polymorphisms are associated with osteopenia in postmenopausal Mayan-Mestizo women	9
Neuroprotective effect of hormone replacement therapy: a review of the literature	9
Premature ovarian insufficiency: addressing the most controversial issues	9
Statement of Retraction: Rapid and random-start endometrial preparation before outpatient hysteroscopic polypectomy in patients of perimenopausal age	9
Chai-shen powder treated perimenopausal syndrome through the PI3K–Akt/cAMP signaling pathway: integrated clinical analysis, network pharmacology, microRNA and animal experiment	9
Menarche, menopause and reproductive span in relation to frailty trajectories in Chinese women	9
Therapeutic effects of curculigoside on cyclophosphamide-induced premature ovarian failure in mice	9
Hot flashes: a potential marker of deterioration of health-related quality of life	8
REDLINC: two decades of collaborative insights into menopause and women’s health in Latin America	8
Body composition and self-perception of age and health in resistance-trained postmenopausal women	8
The association between day-to-day impact of vaginal aging and female sexual function	8
In search of a well-balanced narrative of the menopause momentum	8
Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study	8

The mediating role of socioeconomic status on the relationship between pregnancy history and later-life cognition	8
Prevalence, impact and management of postmenopausal symptoms among postmenopausal women in Rwanda	8
Is it possible that menopause is associated with telomere length? Findings of an integrative review	8
Effect of hormone therapy on personality traits: preliminary evidence in older men and women	8
First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency	8
Testosterone for women: certainties and uncertainties	7
Psychosomatic and medical experiences of menopause in Chinese women: a social media study	7
Sexual dysfunction and quality of life in postmenopausal type 2 diabetes mellitus: clinical and laboratory factors	7
The impact of menopause education on quality of life among menopausal women: a systematic review with meta-analysis	7
Corneal thickness, contrast sensitivity and binocular vision in menopausal and non-menopausal women	7
Pulmonary embolism in menopausal hormone therapy: a population-based register study	7
IMS World Congress on Menopause	7
Rebalancing the narrative on MHT – the menopause momentum continues following FDA ‘unboxing’!	7
Sleep disorders and menopausal symptoms: a Latin American perspective on postmenopausal health	7
Peer reviewers for Climacteric in 2023	7
The role of lifestyle medicine in menopausal health: a review of non-pharmacologic interventions	6
Prevalence of depressive symptoms during the menopausal transition in Türkiye: impact of symptom severity, aging anxiety and health-related quality of life	6
Methodological considerations on insulin resistance and osteoporosis in postmenopausal women	6
Endocrine consequences of breast cancer therapy and survivorship	6
Acupuncture and Chinese herbal medicine for menopausal mood disorder: a randomized controlled trial	6
Medical management of obesity: unlocking the potential	6
Does the environment affect menopause? A review of the effects of endocrine disrupting chemicals on menopause	6
Endometriosis beyond menopause: a call for greater clinical awareness	6
Analysis of multimorbidity patterns in perimenopausal women based on medical examination data	6